SBI Securities’s Phio Pharmaceuticals PHIO Stock Holding History

SBI Securities’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.28K	Hold	1,247	–	–	﹤0.01%	2768
2026 Q2	$1.28K	Buy	1,247 +23	+2%	+$26	﹤0.01%	2711
2026 Q1	$1.49K	Buy	1,224 +89	+8%	+$102	﹤0.01%	2508
2025 Q4	$1.19K	Buy	1,135 +34	+3%	+$54	﹤0.01%	2579
2025 Q3	$2.73K	Sell	1,101 -808	-42%	-$1.84K	﹤0.01%	2305
2025 Q2	$4.49K	Buy	1,909 +941	+97%	+$1.9K	﹤0.01%	2034
2025 Q1	$1.26K	Buy	968 +905	+1,437%	+$1.67K	﹤0.01%	2487
2024 Q4	$113	Buy	+63	New	+$171	﹤0.01%	3423

Other funds holding PHIO

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

SBI Securities's PHIO Position: Q3 2026 in Review

SBI Securities held its Phio Pharmaceuticals (PHIO) position steady in Q3 2026 at 1,247 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

SBI Securities first reported a position in PHIO in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.49K in Q2 2025. 3 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.

SBI Securities held 1,247 shares of Phio Pharmaceuticals worth $1.28K as of Q3 2026.
SBI Securities left its Phio Pharmaceuticals share count unchanged in Q3 2026.
Phio Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2768 holding.
SBI Securities first reported a position in Phio Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Phio Pharmaceuticals position peaked at $4.49K in Q2 2025.
3 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.